BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 17625428)

  • 1. Risk factors for cholangiocarcinoma.
    Ben-Menachem T
    Eur J Gastroenterol Hepatol; 2007 Aug; 19(8):615-7. PubMed ID: 17625428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The epidemiology of cholangiocarcinoma.
    Shaib Y; El-Serag HB
    Semin Liver Dis; 2004 May; 24(2):115-25. PubMed ID: 15192785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholangiocarcinoma: epidemiology, mechanisms of carcinogenesis and prevention.
    Parkin DM; Ohshima H; Srivatanakul P; Vatanasapt V
    Cancer Epidemiol Biomarkers Prev; 1993; 2(6):537-44. PubMed ID: 8268770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cholangiocarcinoma in primary sclerosing cholangitis: "chronicle of a death foretold"?].
    Margalit M; Elinav H; Goldin E; Ilan Y
    Harefuah; 2003 Jun; 142(6):421-5, 486. PubMed ID: 12858825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: a hospital-based case-control study.
    Shaib YH; El-Serag HB; Nooka AK; Thomas M; Brown TD; Patt YZ; Hassan MM
    Am J Gastroenterol; 2007 May; 102(5):1016-21. PubMed ID: 17324130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cholangiocarcinoma in patients with primary sclerosing cholangitis: a multicenter case-control study.
    Chalasani N; Baluyut A; Ismail A; Zaman A; Sood G; Ghalib R; McCashland TM; Reddy KR; Zervos X; Anbari MA; Hoen H
    Hepatology; 2000 Jan; 31(1):7-11. PubMed ID: 10613720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for cholangiocarcinoma.
    Tyson GL; El-Serag HB
    Hepatology; 2011 Jul; 54(1):173-84. PubMed ID: 21488076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence and risk factors for cholangiocarcinoma in primary sclerosing cholangitis.
    Burak K; Angulo P; Pasha TM; Egan K; Petz J; Lindor KD
    Am J Gastroenterol; 2004 Mar; 99(3):523-6. PubMed ID: 15056096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis B virus infection and intrahepatic cholangiocarcinoma in Korea: a case-control study.
    Lee TY; Lee SS; Jung SW; Jeon SH; Yun SC; Oh HC; Kwon S; Lee SK; Seo DW; Kim MH; Suh DJ
    Am J Gastroenterol; 2008 Jul; 103(7):1716-20. PubMed ID: 18557716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatobiliary and extra-hepatic malignancies in primary sclerosing cholangitis.
    Bergquist A; Broomé U
    Best Pract Res Clin Gastroenterol; 2001 Aug; 15(4):643-56. PubMed ID: 11492973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Risk factors of intrahepatic cholangiocarcinoma: a case-control study].
    Zhou HB; Xu QR; Wang H; Zhou DX; Wang H; Wang Q; Zhou SS; Tu QQ; Sun ZQ; Ai L; Wu MC; Hu HP
    Zhonghua Gan Zang Bing Za Zhi; 2009 Dec; 17(12):935-9. PubMed ID: 20038337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical presentation, risk factors and staging systems of cholangiocarcinoma.
    Plentz RR; Malek NP
    Best Pract Res Clin Gastroenterol; 2015 Apr; 29(2):245-52. PubMed ID: 25966425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence rates of intra- and extrahepatic cholangiocarcinomas in Denmark from 1978 through 2002.
    Jepsen P; Vilstrup H; Tarone RE; Friis S; Sørensen HT
    J Natl Cancer Inst; 2007 Jun; 99(11):895-7. PubMed ID: 17551150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Case-control study of risk factors in cholangiocarcinoma].
    Tao LY; He XD; Cai L; Liu W; Ji WJ; Zhao L; Zhang SM
    Zhonghua Zhong Liu Za Zhi; 2009 Oct; 31(10):759-63. PubMed ID: 20021829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cholangiocarcinoma in primary sclerosing cholangitis: who is at risk and how do we screen?
    de Groen PC
    Hepatology; 2000 Jan; 31(1):247-8. PubMed ID: 10613754
    [No Abstract]   [Full Text] [Related]  

  • 16. Bile duct dysplasia in the setting of chronic hepatitis C and alcohol cirrhosis.
    Torbenson M; Yeh MM; Abraham SC
    Am J Surg Pathol; 2007 Sep; 31(9):1410-3. PubMed ID: 17721197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hepatocellular carcinoma and cholangiocarcinoma--different prognosis, pathogenesis and therapy].
    Tischoff I; Tannapfel A
    Zentralbl Chir; 2007 Aug; 132(4):300-5. PubMed ID: 17724632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: a case-control study in China.
    Tao LY; He XD; Qu Q; Cai L; Liu W; Zhou L; Zhang SM
    Liver Int; 2010 Feb; 30(2):215-21. PubMed ID: 19840244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: A systematic review and meta-analysis.
    Clements O; Eliahoo J; Kim JU; Taylor-Robinson SD; Khan SA
    J Hepatol; 2020 Jan; 72(1):95-103. PubMed ID: 31536748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cholangiocarcinoma: risk factors and clinical presentation.
    Gatto M; Alvaro D
    Eur Rev Med Pharmacol Sci; 2010 Apr; 14(4):363-7. PubMed ID: 20496549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.